Tirzepatide 20

Tirzepatide is a highly purified, synthetic dual-agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Supplied in a precise 20mg formulation, this peptide is engineered for advanced in-vitro research and laboratory studies investigating metabolic pathways, incretin receptor signaling, and glycemic regulation.

Product Specifications:

• Peptide: Tirzepatide

• Quantity: 20mg

• Format: Lyophilized powder

• Application: Strictly for laboratory research, analytical studies, and in-vitro use. Not for human consumption.